Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/20/2025

Diagnostic Approach to Irritable Bowel Syndrome

Introduction to Diagnostic Guidelines

  • The British Society of Gastroenterology explicitly states there is no indication for routine gastroscopy in adult IBS patients without upper GI symptoms 1
  • The American Gastroenterological Association recommends against routine colonoscopy in patients under age 50 with typical IBS symptoms and no alarm features 2, 3, 4

Diagnostic Criteria and Procedures

  • The diagnosis of IBS should be made positively based on symptom criteria (Rome IV or similar), not as a diagnosis of exclusion requiring endoscopy 1, 5
  • Colonoscopy should not be performed routinely in patients under age 50 with typical IBS symptoms and no alarm features 2, 3, 4
  • Upper endoscopy should only be performed if patients report upper gastrointestinal symptoms such as dysphagia, persistent vomiting, or epigastric pain that suggests alternative diagnoses like peptic ulcer disease or celiac disease requiring biopsy confirmation 1

Alarm Features Requiring Colonoscopy

  • Any patient with alarm symptoms must undergo colonoscopy regardless of meeting IBS criteria: rectal bleeding, unintended weight loss, anemia or iron deficiency, fever, abnormal physical examination findings, family history of colorectal cancer or inflammatory bowel disease, or age ≥50 years at symptom onset 1, 6, 7

Microscopic Colitis Screening

  • Colonoscopy with biopsies should be considered in IBS-D patients with specific risk factors for microscopic colitis, such as female sex, age ≥50 years, coexistent autoimmune disease, nocturnal diarrhea or severe, watery diarrhea, duration of diarrhea <12 months, weight loss, or use of precipitating medications (NSAIDs, PPIs, SSRIs, statins) 1, 2, 3, 4
  • The prevalence of microscopic colitis in IBS-D cohorts is approximately 1.5%, with all cases identified in the diarrhea-predominant subtype 2, 3, 4

Baseline Tests and Diagnostic Algorithm

  • Before considering any endoscopy, the following baseline tests should be completed: complete blood count, C-reactive protein or ESR, celiac serology (IgA-tTG), and fecal calprotectin (in patients <45 years with diarrhea to exclude IBD) 6, 7
  • If fecal calprotectin is >250 µg/g, colonoscopy is indicated to exclude inflammatory bowel disease 7

Quality of Life Considerations

  • IBS adversely affects health-related quality of life to a degree exceeding most other medical disorders, including impairment of physical, psychosocial, emotional, and role function 5
  • However, unnecessary endoscopic procedures do not improve quality of life and may reinforce illness behavior 1